A major advance in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in various types of cancer, https://free-bookmarking.com/story22029753/vhh-fragments-restore-tumor-suppressor-p53-new-potential-approach-for-tumor-therapy